Levofloxacin Zur Anwendung Bei Erwachsenen Dr. Eberth

Levofloxacin, the active ingredient in Levofloxacin Zur Anwendung Bei Erwachsenen Dr. Eberth, is a fluoroquinolone antibiotic presented as an intravenous solution for parenteral use. It treats a broad range of serious bacterial infections in adult patients.\n\nGNH India supplies Levofloxacin Zur Anwendung Bei Erwachsenen Dr. Eberth as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Levofloxacin is a fluoroquinolone antibiotic used for infections caused by susceptible bacteria.\n\nComplicated urinary tract infections: eradicates Gram‑negative pathogens in adults.\nComplicated intra‑abdominal infections: provides broad‑spectrum coverage after surgical intervention.\nCommunity‑acquired bacterial pneumonia: treats typical and atypical organisms in adult patients.\nSkin and skin‑structure infections: effective against Staphylococcus aureus and other common skin pathogens.\nHospital‑acquired pneumonia: active against multidrug‑resistant respiratory pathogens.

Levofloxacin may cause a range of adverse reactions.\n\nCommon Side Effects:\n- Nausea\n- Diarrhea\n- Headache\n- Dizziness\n- Insomnia\n- Rash\n\nSerious or Rare Side Effects:\n- Tendon rupture or tendinitis\n- QT interval prolongation and cardiac arrhythmias\n- Clostridioides difficile‑associated colitis\n- Severe allergic reactions including anaphylaxis\n- Hepatic dysfunction\n- Seizures, especially in patients with CNS disorders

Levofloxacin requires careful use in several clinical situations.\n\nRenal impairment: dose adjustment may be required.\nHistory of tendon disorders: avoid use due to risk of tendon rupture.\nQT prolongation risk: monitor ECG in patients with cardiac disease.\nPregnancy: use only if benefits outweigh potential risks.\nConcurrent NSAIDs: increased risk of central nervous system stimulation.\nStore at below 25°C: keep in original container, protect from moisture and light.

Levofloxacin can interact with several drug classes, requiring monitoring or avoidance.\n\nMajor Interactions (Avoid):\n- Antacids containing aluminum or magnesium: reduce levofloxacin absorption.\n- Warfarin: may increase INR and bleeding risk.\n- Theophylline: elevated serum concentrations leading to toxicity.\n- Cyclosporine: increased levels and nephrotoxicity.\n- Concurrent fluoroquinolones: additive toxicity.\n\nModerate Interactions (Monitor Closely):\n- Corticosteroids: heightened risk of tendon rupture.\n- Sulfonylureas: potential for hypoglycemia.\n- NSAIDs: possible CNS stimulation.\n- Levodopa: reduced efficacy of Parkinson's medication.\n- Statins: increased risk of myopathy.